C

Cytokinetics Inc.

XNAS · Laboratory Analytical Instruments · S&P 500

$79.11

-$1.33 (-1.65%) today

Open $80.44 High $81.31 Low $78.87 Vol 1,469K Avg $79.75

Related Stocks

Find similar stocks by technical condition — S&P 500 universe

Symbol Company Name Exchange Currency Category
PMN ProMIS Neurosciences Inc. Common Shares (ON) XNAS USD PHARMACEUTICAL PREPARATIONS
EDSA Edesa Biotech, Inc. Common Shares XNAS USD PHARMACEUTICAL PREPARATIONS
KALV KalVista Pharmaceuticals, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS
GERN Geron Corp XNAS USD PHARMACEUTICAL PREPARATIONS
TELO Telomir Pharmaceuticals, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS
XNCR Xencor, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
INO Inovio Pharmaceuticals, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
AMPH Amphastar Pharmaceuticals, Inc. XNAS USD PHARMACEUTICAL PREPARATIONS
AXSM Axsome Therapeutics, Inc XNAS USD PHARMACEUTICAL PREPARATIONS
ANNX Annexon, Inc. Common Stock XNAS USD PHARMACEUTICAL PREPARATIONS

52-week price range

$32.89 $88.31

Price is 140.5% above its 52-week low and 10.4% below its 52-week high. Trading in the upper half of its annual range — closer to the peak than the base.

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

  • Primary Exchange: XNAS
  • Market Cap: 7653049835.2
  • Address:
  • Category: PHARMACEUTICAL PREPARATIONS
  • Total Employees: 673
  • Listing Date: 2004-04-29